Anti-EPS15抗體,價格胞吞調控蛋白Eps15抗體

研究領域 腫瘤  信號轉導  生長因子和激素  
抗體來源 Rabbit
克隆類型 Polyclonal
交叉反應 Human, Mouse, Rat, Pig, 
產品應用 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 （石蠟切片需做抗原修復） 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 99kDa
細胞定位 細胞漿 細胞膜 
性    狀 Lyophilized or Liquid
濃    度 1mg/1ml
免 疫 原 KLH conjugated synthetic peptide derived from human EPS15
亞    型 IgG
純化方法 affinity purified by Protein A
儲 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 
訂購:或（成）客服

英文名稱 EPS15
抗體名稱 Anti-EPS15抗體,價格胞吞調控蛋白Eps15抗體
別    名 AF 1P; AF 1p protein; AF1P; ALL1 fused gene from chromosome 1; Epidermal growth factor receptor pathway substrate 15; Epidermal growth factor receptor substrate 15; EPS 15; MLLT 5; MLLT5; Protein Eps 15; Protein Eps15; EPS15_HUMAN.  

濃 度 1mg/1ml 
規 格 0.1ml/0.2ml(100ug/200ug) 
公司提供的抗體達一萬多種,公司擁有Complexin I/復合素1抗體一抗,二抗,標記一抗,標記二抗等抗體種類,*價供應。
多克隆抗體制備服務：應用保證型抗體制備（ELISA,Western Blot,IHC）和修飾特異性抗體制備（磷酸化,甲基化,乙酰化）。
單克隆抗體制備服務：應用保證型抗體制備（ELISA,Western Blot,IHC）和修飾特異性抗體制備（磷酸化,甲基化,乙酰化）。
抗體純化服務：Protein A/G/L純化,抗原親和純化。
zui終抗體質檢：成品抗體或抗血清,必須通過客戶要求的所有驗證（ELISA,Western Blot,IHC等）。所有的抗原和抗體驗證數據提交客戶。
免疫組化的呈色深淺可反映抗原存在的數量，可作為定性、定位和定量的依據。
1.陽性細胞染色分布有三種類型：細胞漿、細胞核、細胞膜表面。大部分抗原見于細胞漿，可見于整個胞漿或部分胞漿
2.陽性細胞分布可分為灶型和彌漫性
3.由于細胞內含抗原量不同，所以染色強度不一。如果細胞之間染色強度相同，常提示其反應為非特異性
4.陽性細胞染色定位于單個細胞，且與陰性細胞相互交雜分布；而非特異性染色常不限于單個細胞，而是累及一片細胞。
5.切片邊緣、刀痕或褶皺區域，壞死或擠壓的細胞區，膠原結締組織等，常表現為相同的陽性染色強度，不能用于判斷陽性。

產品介紹 Elucidation of the mechanism by which receptor tyrosine kinases (RTKs) modulate cellular physiology in response to stimuli is critical to the understanding of growth regulation. Miscues in RTK signaling pathways can result in cellular transformation and ultimay in cancer. Two novel EGF receptor substrates designated EGF-receptor pathway substrates 8 and 15, or Eps8 and Eps15, have been described. Eps8 and Eps15 are proteins, respectively that become tyrosine phosphorylated subsequent to EGF stimulation. Overexpression of Eps15 in NIH/3T3 cells causes cellular transformation, implying involvement in the regulation of cell proliferation. Eps15 is capable of binding the amino terminal portion of Crk via a conserved proline-rich domain, characteristic of all Crk binding proteins (5). Overexpression of Eps8 in both fibroblasts and hematopoietic cells results in an increased mitogenic response to EGF. Eps8 has been shown to associate with the EGF receptor despite its lack of a functional SH2 domain. Further characterization suggests the protein has both a PH domain and a SH3 domain, the functional significance of which are not yet known.

更多相關產品：

YMK-0233R 端粒酶反轉錄酶抗體 Anti-TERT
YMK-11271R 熱休克蛋白70相互作用蛋白抗體 Anti-HSPABP/HIP/HSC70 Interacting Protein HIP
YMK-1271R 線粒體*蛋白酶抗體 Anti-HtrA2/Omi
YMK-11904R 背板膠質乙酰酯酶抗體 Anti-NOTUM
YMK-1904R 硫酸肝素糖蛋白1抗體抗體 Anti-Syndecan 2/heparin sulphate protoglycans 1
YMK-1387R 熱休克蛋白105抗體 Anti-HSP105
YMK-11387R 芳香乙酰胺脫乙酰基酶樣蛋白4抗體 Anti-AADACL4
YMK-0135R 熱休克蛋白90β/HSP90 β抗體 Anti-HSP90 beta 
YMK-10135R 半胱胺酸蛋白酶蛋白-6抗體 Anti-Caspase-6 subunit p11
YMK-0889R 熱休克蛋白90α/HSP90 α抗體 Anti-HSP90 alpha
YMK-0696R 熱休克蛋白90α抗體 Anti-HSP90 alpha
YMK-1446R 熱休克蛋白75抗體 Anti-HSP75/TRAP1 
YMK-11446R 芳香烴受體核轉錄蛋白樣2抗體 Anti-ARNTL2/BMAL2
YMK-10126R T細胞活化連接蛋白抗體 Anti-LAT/LAT1
YMK-0126R 熱休克蛋白-70抗體 Anti-HSP70